Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma

Cancer

Volumn 94, Issue 11, 2002, Pages 2874-2881

  Takeno, Shinsuke ^a   Noguchi, Tsuyoshi ^a   Kikuchi, Ryuichi ^a   Uchida, Yuzo ^a   Yokoyama, Shigeo ^a   Müller, Wolfram ^b  

^a OITA UNIVERSITY   (Japan)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Cyclin B1; Esophageal squamous cell carcinoma; G2 M checkpoint; p53

Indexed keywords

CYCLIN B1; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CARCINOGENESIS; CORRELATION FUNCTION; DYSPLASIA; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CYCLIN B; EPITHELIUM; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036604222     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10542     Document Type: Article

References (22)

1. Estimates of the world-wide mortality from 25 cancers in 1990
2. p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma
3. Prognostic significance of biologic factors in squamous cell carcinoma of the esophagus
4. Prevalence and predictive value of p53 mutation in patients with oesophageal squamous cell carcinomas: A prospective clinicopathological study and survival analysis of 70 patients
5. p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations
6. No prognostic significance of p53 expression in esophageal squamous cell carcinoma
7. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45
8. GADD45 induction of a G2/M cell cycle checkpoint
9. p53 regulates a G2 checkpoint through cyclin B1
10. p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line
11. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest
12. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication
13. Overexpression of cyclin A and cyclin B1 proteins in astrocytomas
14. Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: Immunocytochemical and quantitative image analyses
15. Prognostic factors in gastric cancer
16. The prognostic significance of proliferation-associated nucleolar protein p120 expression in prostate adenocarcinoma: A comparison with cyclins A and B1, Ki-67, proliferating cell nuclear antigen, and p34cdc2
17. Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma
18. Cellular kinetic differences between Hodgkin's and anaplastic large cell lymphomas: Relation to the expression of p34cdc2 and cyclin B1
19. Expression of the G2-M checkpoint regulators cyclin B1 and P34CDC2 in breast cancer: A correlation with cellular kinetics
20. Expression of PCNA and p53 in esophageal dysplasia and esophageal carcinoma
21. Immune response to cyclin B1 in hepatocellular carcinoma